Wasatch Advisors LP Takes $29.18 Million Position in Billiontoone, Inc. $BLLN

Wasatch Advisors LP purchased a new position in shares of Billiontoone, Inc. (NASDAQ:BLLN) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 369,638 shares of the company’s stock, valued at approximately $29,179,000. Wasatch Advisors LP owned approximately 0.80% of Billiontoone at the end of the most recent reporting period.

Other institutional investors and hedge funds have also modified their holdings of the company. Rossby Financial LCC purchased a new position in Billiontoone in the 4th quarter valued at approximately $25,000. Wells Fargo & Company MN purchased a new stake in Billiontoone during the fourth quarter worth $76,000. Smartleaf Asset Management LLC acquired a new stake in Billiontoone in the fourth quarter valued at $80,000. Nano Cap New Millennium Growth Fund L P acquired a new stake in Billiontoone in the fourth quarter valued at $82,000. Finally, Renaissance Capital LLC purchased a new position in shares of Billiontoone in the fourth quarter valued at $201,000.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on BLLN. Guggenheim lifted their price target on Billiontoone from $100.00 to $120.00 and gave the stock a “buy” rating in a research note on Wednesday, May 13th. Wall Street Zen upgraded shares of Billiontoone from a “hold” rating to a “buy” rating in a report on Saturday, March 7th. BTIG Research dropped their target price on shares of Billiontoone from $140.00 to $130.00 and set a “buy” rating for the company in a report on Thursday, May 7th. JPMorgan Chase & Co. lifted their target price on shares of Billiontoone from $120.00 to $125.00 and gave the stock an “overweight” rating in a research report on Thursday, May 7th. Finally, Wells Fargo & Company reduced their price target on shares of Billiontoone from $110.00 to $90.00 and set an “equal weight” rating on the stock in a report on Thursday, March 5th. Six analysts have rated the stock with a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $125.29.

Billiontoone Stock Performance

Billiontoone stock opened at $118.17 on Friday. Billiontoone, Inc. has a fifty-two week low of $61.96 and a fifty-two week high of $138.70. The company has a market capitalization of $5.43 billion and a price-to-earnings ratio of 214.85. The stock has a fifty day moving average of $92.57 and a two-hundred day moving average of $87.32. The company has a debt-to-equity ratio of 0.18, a quick ratio of 10.58 and a current ratio of 10.92.

Billiontoone (NASDAQ:BLLN) last issued its quarterly earnings data on Wednesday, May 6th. The company reported $0.34 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.01 by $0.33. The company had revenue of $108.39 million during the quarter, compared to analysts’ expectations of $95.81 million. The firm’s revenue was up 83.8% compared to the same quarter last year. During the same quarter in the prior year, the company earned ($0.39) earnings per share. On average, analysts anticipate that Billiontoone, Inc. will post 0.93 EPS for the current fiscal year.

Insider Transactions at Billiontoone

In other Billiontoone news, insider Nancy Joann Johnson sold 10,582 shares of the company’s stock in a transaction dated Tuesday, June 9th. The shares were sold at an average price of $100.47, for a total value of $1,063,173.54. Following the transaction, the insider directly owned 21,900 shares in the company, valued at approximately $2,200,293. This represents a 32.58% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Oguzhan Atay sold 26,250 shares of the firm’s stock in a transaction dated Monday, June 8th. The stock was sold at an average price of $97.66, for a total transaction of $2,563,575.00. Following the sale, the insider directly owned 20,000 shares in the company, valued at $1,953,200. This represents a 56.76% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 91,582 shares of company stock worth $9,192,361 in the last ninety days.

About Billiontoone

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.